Interestingly, a reduction in CX3CR1 expression has been described in blood samples from human Alzheimer’s disease patients [29], indicating that inverse changes between the brain and the periphery may occur in Alzheimer’s disease and supporting the potential of CX3CR1 measurements as an alternative diagnostic tool. The gene discussed is CX3CR1; the disease is early-onset autosomal dominant Alzheimer disease.